Method of lowering serum prolactin

Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Bacterium or component thereof or substance produced by said...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

424247, 424258, 424262, 424274, 424324, A61K 3133, A61K 3147, A61K 3154, A61K 31475

Patent

active

043168973

ABSTRACT:
Benzodiazepine derivatives which have tranquillizing activity, especially 1,4-benzodiazepine derivatives, can lower the serum prolactin concentration. They can reduce, dosage-dependently, the increase in the serum prolactin concentration induced by the administration of neuroleptics, which can lead to undesirable side-effects, when about 0.01 to 100 parts by weight of benzodiazepine derivatives are administered per part by weight of neuroleptic, it being immaterial whether the benzodiazepine derivative is administered before or after the neuroleptic or simultaneously therewith. The simultaneous administration of the active substances can be carried out as an ad hoc combination or in the form of a pharmaceutical combination.

REFERENCES:
patent: 3864486 (1975-02-01), Blum
Merck Index, 9th Ed. (1976) Entry 6391.
Merck Index, 9th Ed. (1976) Entry 8786.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Method of lowering serum prolactin does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method of lowering serum prolactin, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of lowering serum prolactin will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-1774188

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.